There’s disagreement over just how big a role amyloid plays but two drugs that showed modest slowing of the worsening of Alzheimer’s — Leqembi and Kisunla — work by targeting that sticky amyloid plaque. But the NIH’s $3.8 billion budget for Alzheimer’s and similar dementias includes...
NICE agrees to look again at Alzheimer's drug Leqembi Bayer CEO warns of tough 2025 as turnaround plan beds in Sofinnova raises €1.2bn to back 'up to 60' companies Roche ends the 30-year US hiatus in new stroke drugs AbbVie pays Gubra $350m upfront to enter obesity field Ne...
NICE agrees to look again at Alzheimer's drug Leqembi Bayer CEO warns of tough 2025 as turnaround plan beds in Sofinnova raises €1.2bn to back 'up to 60' companies Roche ends the 30-year US hiatus in new stroke drugs AbbVie pays Gubra $350m upfront to enter obesity field Ne...